AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

VOLITIONRX LTD Director's Dealing 2022

Aug 16, 2022

34395_dirs_2022-08-16_c0754502-1ac2-4315-b9e9-ac7c76da4ebb.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-08-15-05:00

Reporting Person: Henshall Mickie (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned	0	Direct